Skip to content

Clinical Investigation to Assess the Performance of the Eureka Electric Breast Pump in Mothers Breastfeeding Their Healthy Term Infant

Clinical Investigation to Assess the Performance of the Eureka Electric Breast Pump in Mothers Breastfeeding Their Healthy Term Infant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03960190
Acronym
EUREKA
Enrollment
40
Registered
2019-05-22
Start date
2019-05-17
Completion date
2019-10-22
Last updated
2019-11-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Pumping

Brief summary

Babies are the best in class in order to get human milk out of a lactating breast. With this in mind, Philips has developed the a new electric breast pump, attempting to mimic the babies sucking behavior. The new electric breast pump includes a new vacuum profile and 2 new expression kits.

Detailed description

Breast pumps currently on the market function by applying vacuum directly to the breast. The effect of a build-up of pressure within the breast due to the accumulation of milk, combined with the external negative pressure introduced by the breast pump, results in the expression of milk. However, in order to express sufficient amounts of milk it is important to stimulate the Milk Ejection Reflex (MER). The MER, also called letdown, draught ejection, expulsion or pumping reflex, is described as a response of the mammary gland to oxytocin. When the nipple is stimulated, the mother's posterior pituitary gland releases oxytocin into the bloodstream. Upon reaching the breast tissue, oxytocin provokes contraction of cells within the structure of the breast causing milk flow. Without the MER successful breastfeeding or breast milk expression cannot happen. In order to stimulate the MER, Philips has developed 2 new expression kits to better mimic the suckling pattern of an infant.

Interventions

DEVICEUsing Eureka Breast Pump with Expression Kit

Each subject will undergo two expression sessions for single and double electric pumping in randomized order to reduce the variation.

Sponsors

Philips Consumer Lifestyle
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The Investigational Device used for this study, is an electric breast pump, intended to express and collect milk from the breast of a lactating woman. Both the 1K and 2K expression kit will be tested in single and double pumping regime.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Have an age between 18 and 50 years * Have delivered a healthy, term singleton infant (with birth weight above 2.5kg and at least 37 weeks gestation) * Have a baby with an age between 1 and 4 months * Exclusively breastfeeding at the time of the study * Have signed the Informed Consent form

Exclusion criteria

* Pregnant at the time of the study * Suffer from known side effects (sore nipples, nipple trauma, bruising, engorgement, clogged mammary ducts, lactostasis, mastitis) at the time of the study * Suffer from syndrome of Raynaud * When providing complementary foods to their baby at the time of the study * When providing donor milk and/or formula milk to their baby at the time of the study * When having their period at the time of the study * When taking oral anticonception at the time of the study

Design outcomes

Primary

MeasureTime frameDescription
Evaluating the performance via percentage of the end milk weight that is expressed during the first 5 minutes after pump start of the Eureka electric breast pump and 1K and 2K expression kits.3 monthsThe data of the expression sessions will be averaged within each of the single and double pumping regimes.

Secondary

MeasureTime frameDescription
Evaluating the performance weight of expressed milk at 1-minute intervals of the Eureka electric breast pump and 1K and 2K expression kits.3 monthsThe data of the expression sessions will be averaged within each of the single and double pumping regimes.
Evaluating the performance via total expression time in minutes of the Eureka electric breast pump and 1K and 2K expression kits.3 monthsThe data of the expression sessions will be averaged within each of the single and double pumping regimes.
Evaluating the performance of time to first milk ejection reflex (MER) pump in seconds of the Eureka electric breast pump and 1K and 2K expression kits.3 monthsThe data of the expression sessions will be averaged within each of the single and double pumping regimes.
Evaluating the performance via weight (grams) of expressed milk after full expression session of the Eureka electric breast pump and 1K and 2K expression kits.3 monthsThe data of the expression sessions will be averaged within each of the single and double pumping regimes.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026